Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy
(Redirected from Nasu-Hakola disease)
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy | |
---|---|
Synonyms | PLOSL, Nasu-Hakola disease |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Dementia, bone cysts, sclerosing leukoencephalopathy |
Complications | N/A |
Onset | Typically in early adulthood |
Duration | Progressive |
Types | N/A |
Causes | Mutations in the TYROBP or TREM2 genes |
Risks | Genetic predisposition |
Diagnosis | Genetic testing, MRI |
Differential diagnosis | Multiple sclerosis, Alzheimer's disease |
Prevention | N/A |
Treatment | Symptomatic management |
Medication | N/A |
Prognosis | Poor, progressive neurological decline |
Frequency | Rare |
Deaths | N/A |
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), also known as Nasu-Hakola disease, is a rare genetic disorder characterized by a combination of progressive presenile dementia and recurrent bone fractures due to bone cysts.
Overview
The disease was initially described in the 1970s in separate reports from Japan by Nasu and from Finland by Hakola, hence its eponymous name. It is a hereditary condition and affects both the central nervous system and the skeletal system.
Symptoms and Clinical Features
Neurological
- Onset of neuropsychiatric symptoms in the 3rd to 5th decade of life
- Progressive presenile dementia
- Personality changes, irritability, and mood disturbances
- Seizures
- Motor symptoms such as rigidity and tremors
Skeletal
- Bone pain and tenderness
- Bone cysts leading to spontaneous fractures, especially in the wrists and ankles
- Radiological evidence showing osteoporosis and polycystic bone lesions
Genetics
Nasu-Hakola disease is inherited in an autosomal recessive manner. It has been linked to mutations in two genes: TREM2 (triggering receptor expressed on myeloid cells 2) and DAP12 (DNAX activation protein 12). Both these genes play vital roles in the functioning of microglial cells in the brain and osteoclasts in the bones.
Diagnosis
The diagnosis of Nasu-Hakola disease involves:
- Clinical evaluation and history taking
- Neuroimaging (MRI) which might reveal white matter changes and atrophy
- Bone X-rays to identify cystic lesions
- Genetic testing to confirm mutations in TREM2 or DAP12
Treatment
There is no specific treatment for Nasu-Hakola disease. Management focuses on:
- Symptomatic relief
- Physiotherapy and orthopedic interventions for bone-related issues
- Neuropsychiatric support and care for cognitive decline
Epidemiology
The condition is extremely rare with higher prevalence noted in Japan and Finland. However, cases have been reported globally.
Prognosis
The disease typically progresses over 10 to 15 years from the onset of symptoms. Most patients become severely debilitated, requiring full-time care, and life expectancy is reduced.
See Also
NIH genetic and rare disease info
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy is a rare disease.
Rare and genetic diseases | ||||||
---|---|---|---|---|---|---|
Rare diseases - Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD